Protective Effect of Infliximab on Ischemia/Reperfusion-Induced Damage in Rat Kidney
dc.authorid | Parlakpınar, Hakan/0000-0001-9497-3468 | |
dc.authorid | Acet, Ahmet/0000-0003-1131-1878 | |
dc.authorid | Ateş, Burhan/0000-0001-6080-229X | |
dc.authorid | Parlakpinar, Hakan/0000-0001-9497-3468 | |
dc.authorid | Vardı, Nigar/0000-0003-0576-1696 | |
dc.authorid | Kati, B/0000-0002-4024-5147 | |
dc.authorid | KARAASLAN, MERVE GOKSIN/0000-0003-2645-808X | |
dc.authorwosid | Parlakpınar, Hakan/T-6517-2018 | |
dc.authorwosid | Acet, Ahmet/AAB-3273-2021 | |
dc.authorwosid | Ateş, Burhan/AAA-3730-2021 | |
dc.authorwosid | Parlakpinar, Hakan/V-6637-2019 | |
dc.authorwosid | Kati, Bulent/AAQ-8835-2020 | |
dc.authorwosid | Vardı, Nigar/C-9549-2018 | |
dc.authorwosid | Kati, B/AGQ-3954-2022 | |
dc.contributor.author | Tasdemir, Cemal | |
dc.contributor.author | Tasdemir, Seda | |
dc.contributor.author | Vardi, Nigar | |
dc.contributor.author | Ates, Burhan | |
dc.contributor.author | Parlakpinar, Hakan | |
dc.contributor.author | Kati, Bulent | |
dc.contributor.author | Karaaslan, Merve Goksin | |
dc.date.accessioned | 2024-08-04T20:36:10Z | |
dc.date.available | 2024-08-04T20:36:10Z | |
dc.date.issued | 2012 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Objective: To investigate the protective effect of infliximab on ischemia-reperfusion (I/R) injury of the rat kidney. Methods: Twenty-eight male Wistar albino rats were divided into four groups: sham-operated, I/R, I/R with infliximab administered before ischemia [I/R + infliximab (bi)], and I/R with infliximab administered before reperfusion [I/R + infliximab (br)]. After a right nephrectomy to produce damage, the left renal vessels were occluded for 60 min, followed by 24-h reperfusion in rats. Changes in the rat kidney were observed by measuring the tissue levels of malondialdehyde (MDA), myeloperoxidase (MPO), glutathione (GSH), and superoxide dismutase (SOD) and by evaluating hematoxylin-eosin (H&E)-stained and periodic acid-Schiff (PAS) sections. Results: The MDA and MPO levels in the I/R group were significantly higher than in the other groups (p < 0.05), and the SOD and GSH levels in the I/R + infliximab (bi) and I/R + infliximab (br) groups were significantly higher than in the I/R group (p < 0.05). However, histological examination revealed that the I/R + infliximab (bi) group and the I/R + infliximab (br) group had significantly fewer tubular changes and interstitial inflammatory cell infiltration than the I/R group. Conclusion: These results show that infliximab may protect against I/R injury in the rat I/R model. | en_US |
dc.identifier.doi | 10.3109/0886022X.2012.717490 | |
dc.identifier.endpage | 1149 | en_US |
dc.identifier.issn | 0886-022X | |
dc.identifier.issn | 1525-6049 | |
dc.identifier.issue | 9 | en_US |
dc.identifier.pmid | 22950848 | en_US |
dc.identifier.scopus | 2-s2.0-84866401335 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 1144 | en_US |
dc.identifier.uri | https://doi.org/10.3109/0886022X.2012.717490 | |
dc.identifier.uri | https://hdl.handle.net/11616/95802 | |
dc.identifier.volume | 34 | en_US |
dc.identifier.wos | WOS:000308956200017 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Taylor & Francis Ltd | en_US |
dc.relation.ispartof | Renal Failure | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | ischemia-reperfusion | en_US |
dc.subject | renal | en_US |
dc.subject | infliximab | en_US |
dc.title | Protective Effect of Infliximab on Ischemia/Reperfusion-Induced Damage in Rat Kidney | en_US |
dc.type | Article | en_US |